Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res (1994) 8.57

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21

Cardiorenal syndrome. J Am Coll Cardiol (2008) 7.09

Rhabdomyolysis and acute kidney injury. N Engl J Med (2009) 6.86

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail (2008) 6.80

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78

A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22

Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation (2004) 3.56

Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol (2008) 3.35

Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15

Cardiovascular disease and subsequent kidney disease. Arch Intern Med (2007) 2.65

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43

Survival trends in ESRD patients compared with the general population in the United States. Am J Kidney Dis (2013) 2.23

Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J (2001) 2.22

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl (2005) 2.10

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int (1995) 2.06

Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis (2011) 2.05

Cardiorenal syndrome: new perspectives. Circulation (2010) 2.03

The role of natriuretic peptides in cardioprotection. Cardiovasc Res (2005) 2.00

Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis (2005) 1.50

Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol (2010) 1.43

Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl (2003) 1.39

Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol (2005) 1.28

Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.21

Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev (2012) 1.07

Oxidative stress in the cardiorenal metabolic syndrome. Curr Hypertens Rep (2012) 1.02

Overview of gender aspects of cardiac syndrome X. Cardiovasc Res (2002) 1.02

Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease? Nephrol Dial Transplant (2010) 0.96

Women, cardiac syndrome X, and microvascular heart disease. Can J Cardiol (2012) 0.94

The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function. Endocrinology (2010) 0.94

Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sci (1997) 0.91

Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke (2013) 0.91

Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--. Circ J (2010) 0.89

Developing and assessing cardiovascular biomarkers. Transl Res (2012) 0.88

Role of renin angiotensin system inhibitors in cardiovascular and renal protection: a lesson from clinical trials. Curr Pharm Des (2007) 0.88

Cardiac isoenzymes in healthy Holstein calves and calves with experimentally induced endotoxemia. Can J Vet Res (2008) 0.85

Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2008) 0.85

Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensus. Nat Clin Pract Nephrol (2008) 0.84

Molecular pathways and crosstalk characterizing the cardiorenal syndrome. OMICS (2012) 0.81

Does the relationship between natriuretic hormones and diastolic function differ by race? Am J Med Sci (2012) 0.79

Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study. Circ Cardiovasc Imaging (2013) 1.37

A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury. Am J Kidney Dis (2015) 1.30

Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT). Am J Kidney Dis (2013) 1.19

Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2014) 0.94

Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Alzheimers Dement (Amst) (2016) 0.90

CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2016) 0.82

Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2016) 0.78

Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2016) 0.75

An NPPB Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality. J Am Heart Assoc (2017) 0.75

Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2017) 0.75